scispace - formally typeset
P

P. K. Saha

Researcher at All India Institute of Medical Sciences

Publications -  23
Citations -  1141

P. K. Saha is an academic researcher from All India Institute of Medical Sciences. The author has contributed to research in topics: Tuberculosis & Odds ratio. The author has an hindex of 14, co-authored 20 publications receiving 1064 citations. Previous affiliations of P. K. Saha include AIIMS, New Delhi.

Papers
More filters
Journal ArticleDOI

Evaluation of Clinical and Immunogenetic Risk Factors for the Development of Hepatotoxicity during Antituberculosis Treatment

TL;DR: The results suggest that the risk of hepatotoxicity from antituberculosis drugs is influenced by clinical and genetic factors.
Journal ArticleDOI

Spectrum of clinical disease in a series of 135 hospitalised HIV-infected patients from north India

TL;DR: A wide spectrum of disease, including both OIs and non-infectious opportunistic diseases, is seen in hospitalised HIV-infected patients from north India and TB remains the most common OI and is the commonest cause of death in these patients.
Journal ArticleDOI

FoxP3+ Regulatory T Cells Suppress Effector T-Cell Function at Pathologic Site in Miliary Tuberculosis

TL;DR: The results highlight the importance of Treg cells in suppression of effector immune response and their influence on bacillary dissemination, disease manifestation, and severity.
Journal Article

A prospective study of sensitivity and specificity of adenosine deaminase estimation in the diagnosis of tuberculosis pleural effusion

TL;DR: It is concluded that, using 100 IU/L as the cut-off, it is possible to avoid pleural biopsy to ascertain the diagnosis of TB in as much as 40% of the patients.
Journal ArticleDOI

Clinical and genetic risk factors for the development of multi-drug resistant tuberculosis in non-HIV infected patients at a tertiary care center in India: a case-control study.

TL;DR: A case-control study at a tertiary care center at New Delhi, India, suggests that a combination of clinical and immunogenetic parameters could provide better information on drug resistance in tuberculosis with implications in therapy.